FDA Adverse Event Malfunction Summary report: N

HEARTSINE SAMARITAN 300P AND PAD PAK

MDR report key: 5821538 · Received July 26, 2016

Report

Report Number
3004123209-2016-00923
Event Type
Malfunction
Date Received
July 26, 2016
Date of Event
June 30, 2016
Report Date
September 2, 2016
Manufacturer
HEARTSINE TECHNOLOGIES LTD
Product Code
MKJ
PMA / PMN Number
K041067
Removal / Correction Number
Z-0124-2013
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
DE, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER E2015058 HEARTSINE TECHNOLOGIES LTD (MANUFACTURER) IS SUBMITTING THE REPORT ON BEHALF OF HEARTSINE TECHNOLOGIES LLC (IMPORTER). H3 OTHER TEXT : NOT YET RETURNED TO MANUFACTURER

Additional Manufacturer Narrative · 0

EXEMPTION NUMBER E2015058. ROUTINE TESTING CONFIRMED THAT THE PAD-PAK WAS FIRST WAS INSTALLED BY THE CUSTOMER ON THE 9TH FEBRUARY 2011 AND PERFORMED TO SPECIFICATION UP TO THE (B)(6) 2015. 68 MANUAL POWER UPS OF UNDER ONE MINUTE DURATION WERE RECORDED AND WOULD LIKELY INDICATE THE USER WAS REGULARLY POWER CYCLING THE DEVICE. THE DEVICE RECORDS MANUAL POWER UPS OF 10 MINUTES DURATION BETWEEN THE (B)(6) 2015 AND THE (B)(6) 2015. THE DEVICE FAILED MULTIPLE SELF-TESTS DUE TO A LOW BATTERY BETWEEN THE (B)(6) 2016. INVESTIGATION FOUND THE FAULT CAN BE ATTRIBUTED TO MEMBRANE FAILURE. THE TEN MINUTE TIME OUTS AND THE EXCESS CURRENT DRAIN MEASURED DURING THE INVESTIGATION WOULD CONFIRM A FAILING MEMBRANE. THE FAULT COULD NOT BE MEASURED WITH A NEW MEMBRANE FITTED. THE PAD-PAK, WHICH CONTAINS THE ELECTRODES AND BATTERIES, IS LABELLED FOR SINGLE USE BUT THE SAMARITAN PAD 300 AND 300P DEVICES ARE FOR MULTI-USE.

Description of Event or Problem · 0

THERE WAS NO PATIENT INVOLVED IN THIS EVENT. DEVICE SWITCHING ON AUTOMATICALLY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
477028 HEARTSINE SAMARITAN 300P AND PAD PAK AUTOMATED EXTERNAL DEFIBRILLATOR MKJ HEARTSINE TECHNOLOGIES LTD SAM N/A

Patients

Seq Age Sex Outcome Treatment
1